With the clinical trial for its COVID-19 vaccine rapidly approaching the end, Johnson & Johnson has revealed its goal of producing enough doses to vaccinate 100 million Americans by April.
from New York Daily News https://ift.tt/3iB704c
With the clinical trial for its COVID-19 vaccine rapidly approaching the end, Johnson & Johnson has revealed its goal of producing enough doses to vaccinate 100 million Americans by April.
No comments:
Post a Comment